enterade® 's Patient Care Blog

Silgan Closures has selected enterade as co-winner of its 2019 annual new product competition.  A medical food product that Entrinsic Health CMO Joe Del Regno says has been called life-changing by ...

Background: Gastroenteropancreatic neuroendocrine tumor (GEPNET) incidence has risen 6-fold over past 3 decades. North American Neuroendocrine Tumor Society estimates that over 100,000 GEPNET patie...

The National Cancer Institute estimates that by 2025, an estimated 2.1 million people in the United States will be diagnosed with cancer every year. This is a 31-percent increase from 2012, which i...

January is Cervical Cancer Awareness Month, and enterade is proud to help raise awareness for a cancer that impacts more than 13,000 women annually. Nearly all cases of cervical cancer are cause...

Entrinsic Health Solutions is pleased to announce that individuals suffering from cancer treatment side-effects such as diarrhea and nausea/vomiting and chronic diarrhea can get convenient local re...

Each New Year provides us with a clean slate, an opportunity to rethink how we approach each day and how we can tackle goals that have seemed out of reach in the past. While obstacles exist for eve...

Managing the side effects of cancer treatment is especially hard during the holidays. Appetite loss, fatigue and nausea don’t pair well with a house full of family and friends. And for those suffer...

Clinical Trial to Assess How enterade® Helps Retain Fluids and Reduce Diarrhea in Carcinoid Syndrome and Neuroendocrine Tumor Patients NORWOOD, Mass., December 12, 2018 – Entrinsic Health Solut...

Cancer patients undergoing treatment can experience debilitating side effects, such as dehydration and damage to the gastrointestinal (GI) system – significantly impacting their quality of life and...

University of Florida startup Entrinsic Health Solutions Inc. (EHS), an innovative health sciences company, has entered into a partnership that provides for a worldwide commercial license and suppl...

— Partnership provides worldwide commercial license and supply agreement for enterade®, an amino acid-based, glucose-free, electrolyte solution designed for oncology and gastrointestinal disease pa...

We are widening the NET! This year, we want to highlight organizations raising awareness about neuroendocrine tumor (NET) cancer – a rare and commonly misdiagnosed form of cancer. NET cancer is fre...